Increased Cellular Death [PE] - N0000009176

Pharmacologic Class Information

Pharmacologic Code N0000009176
Pharmacologic Name Increased Cellular Death
Pharmacologic Uses
  • BCL-2 inhibitor
  • CD22-directed antibody-drug conjugate (ADC)
  • inducer of cell death
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Cellular Death

The following table contains 4 products whose active ingredient are classified under the same pharmacologic class Increased Cellular Death [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0008-0100Besponsa Non-Proprietary Name: Inotuzumab OzogamicinInjection, Powder, Lyophilized, For SolutionIntravenousWyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.ACTIVE
0074-0561Venclexta Non-Proprietary Name: VenetoclaxTablet, Film CoatedOralAbbvie Inc.ACTIVE
0074-0566Venclexta Non-Proprietary Name: VenetoclaxTablet, Film CoatedOralAbbvie Inc.ACTIVE
0074-0576Venclexta Non-Proprietary Name: VenetoclaxTablet, Film CoatedOralAbbvie Inc.ACTIVE